Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups

Treatment of chronic lymphocytic leukemia (CLL) has dramatically changed over the last years, with significant improvement in overall survival (OS) and increased efficacy in genetically defined “high-risk” disease. Besides prospective clinical trials usually enrolling young and fit patients, retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuneo, Antonio, Cavazzini, Francesco, Ciccone, Maria, Daghia, Giulia, Sofritti, Olga, Saccenti, Elena, Negrini, Massimo, Rigolin, Gian Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101746/
https://www.ncbi.nlm.nih.gov/pubmed/24648042
http://dx.doi.org/10.1002/cam4.226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101746/
https://www.ncbi.nlm.nih.gov/pubmed/24648042
http://dx.doi.org/10.1002/cam4.226

Ejemplares similares